Octagon Capital Advisors’s RAPT Therapeutics RAPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-36,500	Closed	-$587K	–	44
2024 Q3	$587K	Hold	36,500	–	–	0.09%	40
2024 Q2	$891K	Hold	36,500	–	–	0.14%	42
2024 Q1	$2.62M	Hold	36,500	–	–	0.31%	48
2023 Q4	$7.26M	Buy	+36,500	New	+$7.26M	1.16%	20